Shalini Sharp

Ms. Shalini Sharp is an Independent Director at Iambic Therapeutics, Inc., an Independent Non-Executive Director at BeOne Medicines Ltd., an Independent Director at Septerna, Inc., an Independent Director at Organon & Co., an Independent Director at Neurocrine Biosciences, Inc. and a Chairman at Mahzi Therapeutics, Inc. She is on the Board of Directors at Iambic Therapeutics, Inc., BeOne Medicines Ltd., Septerna, Inc., Organon & Co., Neurocrine Biosciences, Inc. and Alameda County Community Food Bank.
Ms. Sharp was previously employed as an Independent Director by Mirati Therapeutics, Inc., an Independent Director by Precision BioSciences, Inc., an Independent Director by Sutro Biopharma, Inc., a Treasurer & Vice President by Dimension Therapeutics, Inc., an Independent Director by Array BioPharma, Inc., an Independent Director by Global Alliance for TB Drug Development, a Chief Financial Officer & Senior VP-Finance by Ultragenyx Pharmaceutical, Inc., an Independent Director by Agenus, Inc., a Chief Executive Officer by Elan Corp.
Plc, and a Chief of Staff by Elan Pharmaceuticals, Inc. She also served on the board at Panacea Acquisition Corp.
She received her undergraduate degree from Harvard College and an MBA from Harvard Business School.